drugset / Trial / NCT01478971

Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis

NCT01478971

Phase 3 Completed 184 enrolled Takeda Affymax · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to understand the effects of a dialysis center switching its dialysis patients from using Epoetin alfa to peginesatide injection on hemoglobin levels and other parameters.

Timeline

Start
2011-10
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject epoetin alfa Protein / enzyme biologic Intravenous
Subject peginesatide Peptide Intravenous